Experiment 652681
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | EXTERNAL |
| Organism | Empty organism |
| Citation | CHANG,YC: MAIBACH,HI:. (1997). ADVANCES INN DERMATOPHARMACOLOGY- STRENGTH AND WEAKNESS OF RECENTLY APPROVED DRUGS(1).. 35(5) |
| Amount utilized | |
| Compound isolated | |
| Disease | IN A MULTICENTER, RANDOMIZED, DOUBLE-BLIND STUDY [KULP-SHORTEN ET AL.1993], THE SAFETY AND EFFICACY OF 10% MASOPROCOL (M) AND 5% 5-FLUOROURACIL (5-FU) CREAM WAS TESTED. BY 8 WEEKS, THE NUMBER OF LESIONS WAS REDUCED BY 12.8 /+ 7.3 (97.7% +/ 5.6%) IN THE 5-FU GROUP AND BY 11.3 +/ 6.5 (77.6 +/ 19.3%) IN THE MASOPROCOL GROUP (P<0.0001). 20 OF THE 26 (77%) EVALUABLE 5-FU-TREATED PATIENTS WERE JUDGED TO BE CURED AND 6 (23%) WERE MARKEDLY IMPROVED. 5 OF THE 23 (22%) EVALUABLE MASOPROCOL- TREATED PATIENTS WERE JUDGED CURED, 14 (61%) MARKEDLY IMPROVED, 3 (13%) MODERATELY IMPROVED, AND 1 (4%) WAS ONLY SLIGHTLY IMPROVED (P<0.001). A COMMERCIAL PRODUCT, ACTINEX, WAS USED. |
| Number | 3 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Dose expression | DOSE |
| Gender | GIVEN TO BOTH SEXES |